profit from every $100 of sales.
$0$100
Sintx Technologies
$1.35-12.66% today
-56.0% in 1 year
1-year low $1.351-year high $4.26
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Sintx Technologies sold, what it kept, and what it did with the cash.
Sales went from $601,000 in 2022 to $729,000 in 2025, with -$10.4 million of profit last year.
SalesProfit
Sintx Technologies vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Sintx Technologies | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Sintx Technologies's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 1 | 1 | 1 | |
| 0 | 0 | 0 | 0 | |
| -11 | -13 | -9 | -11 | |
| -11 | -7 | -10 | -10 | |
| -12 | -8 | -11 | -10 | |
| -12,162.00 | -624.47 | -15.19 | -6.16 | |
| 55.9% | 36.1% | 34.9% | 23.6% | |
| -1,886.0% | -1,089.6% | -725.4% | -1,470.6% | |
| -2,003.2% | -673.7% | -884.8% | -1,421.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 16 | 15 | 9 | 10 |
| Cash | 6 | 3 | 4 | 4 |
| Total debt | 3 | 4 | 4 | 3 |
| Total liabilities | 10 | 7 | 6 | 7 |
| 6 | 9 | 4 | 3 | |
| 0 | 0 | 1 | 3 | |
| -110.6% | -50.1% | -109.7% | -131.9% | |
| -211.1% | -94.2% | -283.1% | -353.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -10 | -14 | -9 | -9 | |
| 1 | 1 | 1 | 0 | |
| -12 | -15 | -9 | -9 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 2 |
Valuation
- –
- –
- –
- 2.3×
- 13.9×
- –
- –
- -86.2%
- -101.9%
- 0.0%
Profitability
- 23.6%
- -1,470.6%
- -1,421.7%
- -960.3%
- -173.7%
- -130.5%
- -400.1%
- -179.7%
- -185.7%
- 450.6%
Growth
- +6.6%
- –
- +6.2%
- –
- +91.5%
Financial health
- -0.1×
- 1.11
- 34.1%
- -206.2×
- 1.51
- 1.29
- 0.11
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 35%of 908
Bottom 1%of 991
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -0.70 | -0.66 | −6.1% |
| Mar 18, 2026 | -1.45 | -0.55 | −162.7% |
| Nov 12, 2025 | -3.46 | -0.55 | −529.1% |
| Aug 14, 2025 | -0.91 | -0.79 | −15.2% |
| May 15, 2025 | -1.29 | -0.75 | −72.0% |
| Mar 19, 2025 | -1.14 | -1.82 | +37.4% |
| Nov 12, 2024 | -6.95 | -6.24 | −11.4% |
| Aug 13, 2024 | -3.61 | -996.20 | +99.6% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
33No pass
Philip Fisher
23No pass
Peter Lynch
41No pass
Joel Greenblatt
0No pass
Charlie Munger
20No pass
Terry Smith
18No pass
Questions about Sintx Technologies
Is Sintx Technologies a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Sintx Technologies AI analysis
What does Sintx Technologies do?
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. It is in Medical - Devices.
Does Sintx Technologies pay a dividend?
No. Sintx Technologies does not pay a dividend at the moment; in 2025 it returned $133,000 to shareholders by buying back its own shares.
Is Sintx Technologies stock halal?
No. Sintx Technologies does not pass our halal screen: its cash and confirmed interest-bearing investments are 41% of its market value, at or above the 33% limit. How we check
How has Sintx Technologies stock done over the past year?
Down 56.0% over the past twelve months, to $1.35. It traded between $1.35 and $4.26 and is 68.4% below its high.
Who are Sintx Technologies's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Sintx Technologies's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.